药物信息为ONGLYZA (saxagliptin) tablets Initial U.S. Approval: 2009 (E.R. Squibb & Sons, L.L.C.): 4 CONTRAINDICATIONS

Ads
  • Drug Information Provided by National Library of Medicine (NLM).
Ads